You just read:

Amsterdam Molecular Therapeutics Presents Data Supporting Role of Chylomicron Clearance as Marker for Glybera(R) Efficacy

News provided by

Amsterdam Molecular Therapeutics B.V

May 20, 2011, 01:00 ET